Guilherme Dias Melo et al.
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
EMBO Molecular Medicine 2021
doi: 10.15252/emmm.202114122

Guilherme Dias Melo et al.
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
EMBO Molecular Medicine 2021
doi: 10.15252/emmm.202114122